1990
DOI: 10.1007/bf00193204
|View full text |Cite
|
Sign up to set email alerts
|

Improved fragile site detection with trimethoprim

Abstract: The effect of trimethoprim, an inhibitor of dihydrofolate reductase, in demonstrating the presence of fragile sites on human chromosomes was investigated. Lymphocyte cultures with 20 mg/l trimethoprim added at the onset of incubation gave consistently higher frequencies of fragile sites than the other culture regimes tested.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1993
1993
2010
2010

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…As a folic acid (folate) antagonist, TRIMP inhibits the action of dihydrofolate reductase enzyme which is responsible for the conversion of the dihydrofolate to tetrahydrofolate affecting the biosynthesis of nucleotides (Mclean and Faed 1990;Baccanari 1995). It is now well established that folate deficiency can play an important role in carcinogenesis and its antagonists have been shown to induce the entire range of genetic events commonly associated with environmental genotoxic agents.…”
Section: Introductionmentioning
confidence: 99%
“…As a folic acid (folate) antagonist, TRIMP inhibits the action of dihydrofolate reductase enzyme which is responsible for the conversion of the dihydrofolate to tetrahydrofolate affecting the biosynthesis of nucleotides (Mclean and Faed 1990;Baccanari 1995). It is now well established that folate deficiency can play an important role in carcinogenesis and its antagonists have been shown to induce the entire range of genetic events commonly associated with environmental genotoxic agents.…”
Section: Introductionmentioning
confidence: 99%